Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2026-01-03 @ 10:25 PM
Study NCT ID:
NCT04697069
Status:
TERMINATED
Last Update Posted:
2025-09-22
First Post:
2020-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
Sponsor:
Vanda Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-04
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-13
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-23
First Submit QC Date:
None
Study First Post Date:
2021-01-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-14
Results First Submit QC Date:
None
Results First Post Date:
2023-01-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-02
Last Update Post Date:
2025-09-22
Last Update Post Date Type:
ESTIMATED